# Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients

> **NCT03314493** · PHASE3 · COMPLETED · sponsor: **Professor Fernando Figueira Integral Medicine Institute** · enrollment: 33 (actual)

## Conditions studied

- Coronary Artery Calcification
- Vascular Calcification

## Interventions

- **DRUG:** Spironolactone 25Mg Tablet

## Key facts

- **NCT ID:** NCT03314493
- **Lead sponsor:** Professor Fernando Figueira Integral Medicine Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-07
- **Primary completion:** 2016-11-10
- **Final completion:** 2016-11-10
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-10-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03314493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03314493, "Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03314493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*